Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420

Frank S. Lieberman, Meihua Wang, H. Ian Robins, Christina I. Tsien, Walter J. Curran, Maria Werner-Wasik, Ryan P. Smith, Christopher Schultz, Alan C. Hartford, Peixin Zhang, Minesh P. Mehta

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)878-886
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume103
Issue number4
DOIs
StatePublished - Mar 15 2019
Externally publishedYes

ASJC Scopus Subject Areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this